SPY
769.86
+0.03%
QQQ
749.55
−0.00%
BTC/USD
84,851.23
+0.41%
DIA
511.70
+0.12%
GLD
380.52
+0.10%
TLT
77.53
+0.06%
US
Sign in
Register
My Account
Benzinga
Markets & News
Markets
Stocks & Sectors
Stocks
Ratings & Research
Ratings
Trading
Trading
Screeners & Lists
Screeners
Learn
Learn
Premium
Premium Services
Markets & News
Breaking headlines, the trading day, and the calendars that move it.
Stocks & Sectors
Research any ticker, then drill into sectors, ratings, and options.
Ratings & Research
Wall Street calls, insider moves, and Benzinga's own stock rankings.
Trading
Options flow, trade calculators, and ideas for active traders.
Screeners & Lists
Filter the market your way, or start from a curated list.
Learn
Pick a broker, grow your savings, and protect what you've built.
Premium Services
Edge
Ratings, signals & screens
Pro
Real-time news & data terminal
Research
Trade alerts & newsletters
APIs
Market data licensing
All sections
Haleon PLC
HLN
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$8.80
0.08
0.92%
Last update: Oct 2, 4:36 PM
$8.81
0.0855
0.98%
Get Report
Overview
News
Earnings Forecast
Price Targets
Financials
Sentiment
Ownership
Dividends
Compare
Options
Stock Report
Privacy Manager
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga
Edge
Benzinga
Research
Benzinga
Pro
Logout
Haleon Financials
Haleon (HLN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Haleon H1 Adj. EPS $0.14 Up From $0.12 YoY, Sales $7.533B Beat $3.600B Estimate
Haleon (NYSE:HLN) reported quarterly earnings of $0.14 per share. This is a 16.67 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $7.533 billion
Benzinga Newsdesk
Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains weighted to the second half.
Vandana Singh
PRO
Haleon Sees FY25 Organic Revenue Growth Of 4%-6%, Allocates GBP500M For Share Buybacks
Benzinga Newsdesk
PRO
Haleon FY Adjusted EPS GBp17.9 Up From GBp17.3 YoY, Sales GBP11.2B Down From GBP11.3B YoY
Benzinga Newsdesk
Earnings Scheduled For February 27, 2025
Benzinga Insights
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and global generics expansion.
Vandana Singh
